Clinical trials sponsored by Vanderbilt University Medical Center
46
Recruiting trials
15
Conditions studied
Phase breakdown
Early Phase 1 3Phase 1 3Phase 2 7Phase 3 1Phase 4 2Not applicable 32
Conditions studied
Recruiting trials led by Vanderbilt University Medical Center
- 2-HOBA in Systemic Lupus Erythematosus
- 2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)
- CPAP for the Treatment of Supine Hypertension
- Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes
- Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition
- CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease
- Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
- Cooperative Assessment of Late Effects for SCD Curative Therapies
- Corticostriatal Contributions to Parkinson's Disease Cognitive Impairment
- Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage
- Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies
- Effect of Raised Head of the Bed on Lying Blood Pressure in Autonomic Failure
- Effect of Rose Odor Exposure on Ictal Apnea
- Exercise Testing After Preeclampsia
- GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
- GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
- Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
- Gut Microbiota in Metabolic Surgery
- Healer-initiated HIV Counseling and Testing Versus Standard of Care in Rural South Africa
- Home-Based Cardiac Rehabilitation for Patients With Heart Failure
- Hormonal, Metabolic, and Signaling Interactions in PAH
- Impact of Pelvic Pain Podcast
- Mechanistic Study of Nicotinamide Riboside on NAD+ Biology in Individuals With Combined Pulmonary Hypertension
- Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
- Mobile Health Intervention to Improve Exercise in Pediatric PH
- NICU Utilization of Remote Voice Technology to Improve mateRnal Experience (NURTURE)
- Neurophysiology of Reward Signaling in Parkinson's Disease
- Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension
- Physiological Brain Atlas Development
- Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia
- Reducing Overuse of Antibiotics With Decision Support
- Reducing Perioperative Oxidative Stress to Prevent Postoperative Chronic Pain Following Total Knee Arthroplasty
- Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals
- Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
- Stroke Prevention in Nigeria 2 Trial
- Swallowing Impairments in Adults With and Without Alzheimer's Disease
- Sympathetic Mechanisms in Obesity-Crossover Design
- Tennessee Alzheimer's Project
- The ADAPT Trial: Adapting Evidence-Based Obesity Interventions in Community Settings
- The Dose Trial: Dose Intensity of Behavioral Interventions for Childhood Obesity
- The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
- The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study
- Treatment of Supine Hypertension in Autonomic Failure (CPAP)
- Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy
- Wearable Technology to Evaluate Hyperglycemia and HRV in DMD
- Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim
Common questions
How many trials is Vanderbilt University Medical Center recruiting for?
Vanderbilt University Medical Center is the lead sponsor of 46 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.